Safety and effectiveness of central venous catheterization in patients with cancer: Prospective observational study

Journal of Korean Medical Science

Volumn 25, Issue 12, 2010, Pages 1748-1753

  Kim, Hyun Jung ^a   Yun, Jina ^a   Kim, Han Jo ^a   Kim, Kyoung Ha ^a   Kim, Se Hyung ^a   Lee, Sang Cheol ^a   Bae, Sang Byung ^a   Kim, Chan Kyu ^a   Lee, Nam Su ^a   Lee, Kyu Taek ^a   Park, Seong Kyu ^a   Won, Jong Ho ^a   Park, Hee Sook ^a   Hong, Dae Sik ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Catheterization; Central venous; Complications; Neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CATHETER INFECTION; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; EQUIPMENT; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; RISK FACTOR; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; EQUIPMENT FAILURE; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 78649956145     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.12.1748     Document Type: Article

References (27)

1. Scott WL. Central venous catheters. An overview of Food and Drug Administration activities. Surg Oncol Clin N Am 1995; 4: 377-93.
2. Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. Complications and failures of subclavian-vein catheterization. N Engl J Med 1994; 331: 1735-8.
3. Yildizeli B, Laçin T, Batirel HF, Yüksel M. Complications and management of long-term central venous access catheters and ports. J Vasc Access 2004; 5: 174-8.
4. Cortelezzia A, Fracchiolla NS, Maisonneuve P, Moia M, Luchesini C,Ranzi ML, Monni P, Pasquini MC, Lambertenghi-Deliliers G. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma 2003; 44: 1495-501.
5. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123-33.
6. Vescia S, Baumgärtner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S, Harbeck N. Management of venous port systems in oncology: a review of current evidence. Ann Oncol 2008; 19: 9-15.
7. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin 2008; 58: 323-46.
8. Kim JT, Oh TY. Clinical review of totally implantable venous catheter. Korean J Thorac Cardiovasc Surg 2007; 40: 691-5.
9. Cho SG, Kim SH, Song HH, Song SH, Lee KH, Chung DY, Lee HJ, Kim SH, Kim KT, Kim CC. Radiologic placement of subcutaneous infusion ports in cancer patients: analysis of 45 cases. J Korean Cancer Assoc 2000; 32: 1115-21.
10. Ryder MA. Peripheral access options. Surg Oncol Clin N Am 1995; 4: 395-427.
11. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, Mc- Dougall C, Wilcox MH. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65 Suppl 1: S1-64.
12. King MM, Rasnake MS, Rodriguez RG, Riley NJ, Stamm JA. Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients. South Med J 2006; 99: 1073-7.
13. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995; 75: 1367-75.
14. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-40.
15. Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology 2008; 74: 237-44.
16. Camargo LF, Marra AR, Büchele GL, Sogayar AM, Cal RG, de Sousa JM, Silva E, Knobel E, Edmond MB. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. J Hosp Infect 2009; 72: 227-33.
17. Lee DH, Jung KY, Choi YH. Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008; 29: 947-50.
18. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-8.
19. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A. Upper extremity deep venous thrombosis in cancer patients with venous access devices prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-3.
20. Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR. Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter-Associated Thrombosis in Patients With Cancer. J Clin Oncol 2005; 23: 4063-9.
21. Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 2002; 32: 84-8.
22. Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, Shepherd S, Stanley A, Sweeney A, Wilde J, Wheatley K; WARP Collaborative Group, UK. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009; 373: 567-74.
23. Svoboda P, Barton RP, Barbarash OL, Butylin AA, Jacobs BR, Lata J, Haire WD, Jaff MR, Firszt CM, Mouginis TL, Schuerr DM, Schulz GA, Schwartz LB, El-Shahawy MA. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med 2004; 32: 1990-6.
24. Schindler J, Bona RD, Chen HH, Feingold JM, Edwards RL, Tutschka PJ, Bilgrami S. Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue. Clin Appl Thromb Hemost 1999; 5: 25-9.
25. Grove JR, Pevec WC. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol 2000; 11: 837-40.
26. Loewenthal MR, Dobson PM, Starkey RE, Dagg SA, Petersen A, Boyle MJ. The peripherally inserted central catheter (PICC): a prospective study of its natural history after cubital fossa insertion. Anaesth Intensive Care 2002; 30: 21-4.
27. Gabriel J. PICC securement: minimising potential complications. Nurs Stand 2001; 15: 42-4.